EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

The past, present and future of penile cancer in the Nordic countries. Results from NORDCAN

Christian Arvei Moen iD, Axel Gerdtsson, Mikael Aagaard, Andreas Hopland, Peter Kirrander, Jakob Kristian Jakobsen iD

BJUI Compass · 2025-07 · 6 (7)

DOI: 10.1002/bco2.70041 ↗

Kurz gefasst

Fachartikel in der Zeitschrift BJUI Compass, online erschienen am 27.06.2025. Verfasst von Christian Arvei Moen und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Urology Haukeland University Hospital Bergen Norway. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 31 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objectives

This work aims to present epidemiological data on penile cancer from the Nordic region (Denmark, Finland, Iceland, Norway, Sweden) and discuss the results in light of the present knowledge and possible future treatment strategies. Patients and Methods All patients diagnosed with penile cancer in the Nordic countries between 2000 and 2022 were identified in the NORDCAN database. Data on the number of new cases per year, incidence (presented as an age‐standardized rate using the Nordic population as a reference), prevalence, mortality, relative survival and predictions on the future societal impact of this cancer was retrieved.

Results

A total of 6106 cases of penile cancer were registered in a population that increased from about 12–14 million men over the period. The age‐standardized incidence has significantly increased over time and is now above 2.0 per 100 000 men. Currently, more than 300 new cases are diagnosed each year, and more than 3000 men live with a penile cancer diagnosis. Mortality, as well as both 1‐year and 5‐year relative survival have, however, remained nearly unchanged. Using the NORPRED model, it is predicted that the yearly number of penile cancer cases will continue to increase in all the countries investigated over the next decade.

Conclusion

Penile cancer incidence and prevalence have increased in the Nordic region over the last 20 years. Mortality and survival, however, have remained unchanged. The number of new penile cancer cases is predicted to increase over the next decade. Better treatment options for these patients are therefore urgently needed.

Schlagwörter

Stichwörter der Autor:innen

NORDCAN databaseincidencepenile cancersurvivaltime trends

Autor:innen und Institutionen

  • Department of Urology Haukeland University Hospital Bergen Norway.
  • Department of Clinical Medicine University of Bergen Bergen Norway.
  • Department of Urology Skåne University Hospital Malmö Sweden.
  • Department of Translational Medicine Lund University Lund Sweden.
  • Department of Urology Rigshospitalet University Hospital Copenhagen Denmark.
  • Department of Urology Oslo University Hospital Oslo Norway.

ORCID-Profile: Christian Arvei Moen, Jakob Kristian Jakobsen

Zitieren

APA

Moen, C. A., Gerdtsson, A., Aagaard, M., Hopland, A., Kirrander, P., & Jakobsen, J. K. (2025). The past, present and future of penile cancer in the Nordic countries. Results from NORDCAN. BJUI Compass, 6(7). https://doi.org/10.1002/bco2.70041

Vancouver

Moen CA, Gerdtsson A, Aagaard M, Hopland A, Kirrander P, Jakobsen JK. The past, present and future of penile cancer in the Nordic countries. Results from NORDCAN. BJUI Compass. 2025;6(7). doi:10.1002/bco2.70041

BibTeX
@article{Moen2025,
  author = {Moen, Christian Arvei and Gerdtsson, Axel and Aagaard, Mikael and Hopland, Andreas and Kirrander, Peter and Jakobsen, Jakob Kristian},
  title = {The past, present and future of penile cancer in the Nordic countries. Results from NORDCAN},
  journal = {BJUI Compass},
  year = {2025},
  volume = {6},
  number = {7},
  doi = {10.1002/bco2.70041}
}
Kostenlos starten →